Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-16-Speech-3-209-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-02-16"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20110216.11.3-209-000"2
lpv:hasSubsequent	lp_eu:2011-02-16-Speech-3-210-0002
lpv:speaker	lp:Diogo Feio2
lpv:spokenAs	substitute; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-16--2014-06-30)3 unknown; Partido Popular (2009-07-14--2014-06-30)3 member; Delegation to the EU-Kazakhstan, EU-Kyrgyzstan and EU-Uzbekistan Parliamentary Cooperation Committees, and for relations with Tajikistan, Turkmenistan and Mongolia (2009-09-16--2014-06-30)3 member; ECON (2009-07-16--2012-01-18)3 member; EPP (2009-07-14--2014-06-30)3 substitute; AFET (2009-07-16--2012-01-18)3 substitute; Special Committee on the Financial, Economic and Social Crisis (2009-10-08--2011-07-31)3
lpv:translated text	"I believe that consumer safety is a matter of vital importance, particularly when the consumers involved are also patients who are seeking a cure from the medicines they take, or at least a significant improvement in their health. Consumer safety is of even greater importance when it aims to safeguard the authenticity of medicinal products sold on the open market, whether through traditional channels or over the Internet. For this very reason, I consider it vital that very clear regulations be adopted on the falsification of medicinal products, as this is a growing phenomenon throughout Europe and the rest of the world which has devastating effects on consumer confidence, on companies and, even more importantly, on the health of those who take these falsified medicines. I therefore support this report and would congratulate Mrs Matias on the work she has carried out and on all the compromises that she has negotiated."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph